CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Get Free Report) saw a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 2,300 shares, a drop of 66.2% from the May 15th total of 6,800 shares. Currently, 0.0% of the company’s stock are sold short. Based on an […]
CollPlant Biotechnologies (NASDAQ:CLGN – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, May 29th. Analysts expect the company to announce earnings of ($0.35) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. […]
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Free Report) – Analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for CollPlant Biotechnologies in a note issued to investors on Friday, April 5th. HC Wainwright analyst S. Ramakanth anticipates that the company will post earnings of ($0.36) per share for the quarter. HC Wainwright currently […]
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Get Free Report) was the recipient of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 11,500 shares, a decline of 18.4% from the November 30th total of 14,100 shares. Based on an average trading volume of 14,800 shares, […]
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Get Free Report)’s share price traded up 0.3% during trading on Tuesday . The company traded as high as $5.70 and last traded at $5.68. 13,581 shares traded hands during trading, a decline of 1% from the average session volume of 13,698 shares. The stock had previously closed at $5.66. […]